How Genomic Testing is Transforming Treatment Decisions in Intermediate-Risk Prostate Cancer September 4, 2025 By Lauren Lenz, Christina Nakamoto, & Robert Finch In men with prostate cancer, few decisions are as difficult—or as emotionally charged—as choosing... Continue Reading
50 Years After the Monoclonal Antibody Breakthrough: Why Precision Medicine Still Needs Reinventing September 4, 2025 In July 1975, a scientific paper in Nature by César Milstein and Georges Köhler described how to produce monoclonal antibodies: highly specific, identical im... Continue Reading
What Does RNA Analysis Actually Add to Hereditary Cancer Testing? July 7, 2025 Not All RNA Analysis Is Created Equal Genetic testing has transformed how we understand cancer risk. For nearly three decades, DNA-based analysis has been t... Continue Reading